PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-4.68%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.55B
AUM Growth
+$3.55B
(-10%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-4.68%
Top 10 Holdings %
Top 10 Hldgs %
43.47%
Holding
106
New
18
Increased
23
Reduced
23
Closed
36
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$165M |
| 2 |
Pfizer
PFE
|
$156M |
| 3 |
UnitedHealth
UNH
|
$121M |
| 4 |
Gilead Sciences
GILD
|
$111M |
| 5 |
Eli Lilly
LLY
|
$92.6M |
Top Sells
| 1 |
Elevance Health
ELV
|
$84.3M |
| 2 |
Apple
AAPL
|
$80.7M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
$75.4M |
| 4 |
VMW
VMware, Inc
VMW
|
$72.2M |
| 5 |
Tenet Healthcare
THC
|
$67M |
Sector Composition
| 1 | Healthcare | 59.59% |
| 2 | Communication Services | 6.35% |
| 3 | Financials | 5.67% |
| 4 | Technology | 4.96% |
| 5 | Consumer Discretionary | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fortune Brands Innovations
FBIN
$6.86B
| $48.3M | 1.36% |
+1,018,137
| New | +$48.3M |
|
27
Ally Financial
ALLY
$12.6B
| $47.9M | 1.35% |
2,348,383
+1,377,572
| +142% | +$28.1M |
|
28
Mastercard
MA
$536B
| $45.1M | 1.27% |
+500,093
| New | +$45.1M |
|
29
JD.com
JD
$44.2B
| $44.1M | 1.24% |
1,693,324
+362,193
| +27% | +$9.44M |
|
30
Jazz Pharmaceuticals
JAZZ
$7.99B
| $43.3M | 1.22% |
326,002
-139,412
| -30% | -$18.5M |
|
31
Alphabet (Google) Class C
GOOG
$2.79T
| $42.3M | 1.19% |
+66,310
| New | +$42.3M |
|
32
Eagle Materials
EXP
$7.27B
| $40.1M | 1.13% |
586,800
-418,939
| -42% | -$28.7M |
|
|
RDUS
33
DELISTED
Radius Health, Inc.
RDUS
| $40M | 1.13% |
577,034
-186,262
| -24% | -$12.9M |
|
|
AERI
34
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $39.4M | 1.11% |
2,218,198
+366,634
| +20% | +$6.5M |
|
35
MGIC Investment
MTG
$6.47B
| $38M | 1.07% |
4,104,737
-835,000
| -17% | -$7.73M |
|
|
KITE
36
DELISTED
Kite Pharma, Inc.
KITE
| $38M | 1.07% |
682,577
+373,425
| +121% | +$20.8M |
|
|
ALDR
37
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $36.2M | 1.02% |
1,105,911
+352,630
| +47% | +$11.6M |
|
38
Humana
HUM
$37.5B
| $33.5M | 0.94% |
186,935
-256,128
| -58% | -$45.8M |
|
|
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $32M | 0.9% |
+758,816
| New | +$32M |
|
|
LNKD
40
DELISTED
LinkedIn Corporation
LNKD
| $28.9M | 0.81% |
151,848
-78,597
| -34% | -$14.9M |
|
41
Accuray
ARAY
$165M
| $28.8M | 0.81% |
5,771,250
+1,342,989
| +30% | +$6.71M |
|
42
Netflix
NFLX
$521B
| $27.9M | 0.79% |
270,633
+240,151
| +788% | +$5.91M |
|
43
Liberty Global Class C
LBTYK
$4.1B
| $27.9M | 0.79% |
680,964
-1,434,833
| -68% | -$65.2M |
|
|
THOR
44
DELISTED
THORATEC CORPORATION
THOR
| $27.4M | 0.77% |
432,577
-297,497
| -41% | -$18.8M |
|
|
AIMT
45
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $25.2M | 0.71% |
+996,112
| New | +$25.2M |
|
|
ACOR
46
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $24.2M | 0.68% |
913,674
+96,278
| +12% | +$2.55M |
|
|
RAD
47
DELISTED
Rite Aid Corporation
RAD
| $21.8M | 0.61% |
3,583,282
-2,035,317
| -36% | -$12.4M |
|
|
BPMC
48
DELISTED
Blueprint Medicines
BPMC
| $21M | 0.59% |
1,027,553
+165,388
| +19% | +$3.38M |
|
49
Molina Healthcare
MOH
$9.6B
| $15.7M | 0.44% |
228,635
+61,401
| +37% | +$4.23M |
|
50
Penumbra
PEN
$10.5B
| $15.3M | 0.43% |
+381,270
| New | +$15.3M |
|